Advocacy intelligence hub — real-time data for patient organizations
ML Bio Solutions, Inc. — PHASE3
ML Bio Solutions, Inc. — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all FKRP-related limb-girdle muscular dystrophy R9 news →
Amy Harper, MD
Virginia Commonwealth University
Nicholas Johnson, MD
Virginia Commonwealth University
📍 Richmond, Virginia
Kathryn R Wagner, MD/PhD
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Nicoline Løkken, Bsc
Neuromuscular Research Unit, Rigshospitalet, Copenhagen
Susan Sparks, M.D., Ph.D.
Levine Children's Hospital
John Vissing, PR
Professor of neurology
View all FKRP-related limb-girdle muscular dystrophy R9 specialists →